Taysha Gene Therapies (TSHA) Insider Trading & Ownership $1.28 +0.04 (+2.81%) As of 04/14/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Taysha Gene Therapies (NASDAQ:TSHA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.70%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$3.00 MNumber OfInsiders Selling(Last 12 Months)0 Get TSHA Insider Trade Alerts Want to know when executives and insiders are buying or selling Taysha Gene Therapies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TSHA Insider Buying and Selling by Quarter Remove Ads Taysha Gene Therapies Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/27/2024Paul B ManningMajor ShareholderBuy1,333,333$2.25$2,999,999.25 (Data available from 1/1/2013 forward) TSHA Insider Trading Activity - Frequently Asked Questions Who is on Taysha Gene Therapies's Insider Roster? The list of insiders at Taysha Gene Therapies includes John A Stalfort III, Kamran Alam, Paul B Manning, R.A. Session II, Sean P Nolan, Sukumar Nagendran, and Suyash Prasad. Learn more on insiders at TSHA. What percentage of Taysha Gene Therapies stock is owned by insiders? 2.70% of Taysha Gene Therapies stock is owned by insiders. Learn more on TSHA's insider holdings. Which Taysha Gene Therapies insiders have been buying company stock? The following insiders have purchased TSHA shares in the last 24 months: John A Stalfort III ($350,000.10), Paul B Manning ($17,982,999.55), Sean P Nolan ($399,999.60), and Sukumar Nagendran ($3,400.00). How much insider buying is happening at Taysha Gene Therapies? Insiders have purchased a total of 18,738,333 TSHA shares in the last 24 months for a total of $18,736,399.25 bought. Which Taysha Gene Therapies insiders have been selling company stock? The following insiders have sold TSHA shares in the last 24 months: Kamran Alam ($76,890.00), and R.A. Session II ($274,444.11). How much insider selling is happening at Taysha Gene Therapies? Insiders have sold a total of 419,689 Taysha Gene Therapies shares in the last 24 months for a total of $351,334.11 sold. Taysha Gene Therapies Key ExecutivesMr. Sean P. Nolan (Age 56)CEO & Chairman Compensation: $925.33kDr. Sukumar Nagendran M.D. (Age 57)President, Head of Research & Development and Director Compensation: $820.59kMr. Kamran Alam CPA (Age 46)M.B.A., CFO & Corporate Secretary Compensation: $573.36kHayleigh CollinsDirector of Corporate Communications & Investor RelationsMs. Tracy M. Porter SPHRChief People OfficerMr. Frederick Porter Ph.D.Chief of Staff & Technical Operations OfficerMs. Emily McGinnis M.P.H.Chief Patient Advocacy & External Affairs OfficerMr. Sean McAuliffeChief Business OfficerDr. Steven Gray Ph.D.Chief Scientific Advisor of UT Southwestern Gene Therapy ProgramBerge Minassian M.D.Chief Medical Advisor of UT Southwestern Gene Therapy Program More Insider Trading Tools from MarketBeat Related Companies OCUL Insider Selling IOVA Insider Selling SNDX Insider Selling WVE Insider Selling COLL Insider Selling ELVN Insider Selling DYN Insider Selling GPCR Insider Selling ETNB Insider Selling CMRX Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market SentimentMicroStrategy Sees Insider Buy-Sell Action in Q1Casey’s General Stores Insider Buys Shares of This Must-Own StockNVIDIA Insiders Sell: This Is What It Means for the Market This page (NASDAQ:TSHA) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Taysha Gene Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Taysha Gene Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TSHA Stock Free TSHA Stock Alerts